Company Filing History:
Years Active: 2017-2020
Title: Thirunavukkarasu Velusamy: Innovator in Cancer Research
Introduction
Thirunavukkarasu Velusamy is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer research, particularly in the development of diagnostic markers and therapeutic targets.
Latest Patents
Velusamy holds 2 patents that focus on innovative approaches to cancer diagnosis and treatment. His latest patents include:
1. **Recurrent gene fusions in cutaneous CD30-positive lymphoproliferative disorders** - This invention provides kits, compositions, and methods for cancer diagnosis, research, and therapy. It specifically relates to recurrent gene fusions, such as translocations involving TYK2, which serve as diagnostic markers and clinical targets for conditions like lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
2. **RNA chimeras in human leukemia and lymphoma** - This patent also offers kits, compositions, and methods for cancer diagnosis, research, and therapy. It focuses on recurrent RNA fusions as diagnostic markers and clinical targets for leukemia.
Career Highlights
Thirunavukkarasu Velusamy is affiliated with the University of Michigan, where he continues to advance his research in cancer diagnostics and therapeutics. His work has garnered attention for its potential impact on improving patient outcomes in oncology.
Collaborations
Velusamy collaborates with notable colleagues, including Kojo Elenitoba-Johnson and Megan Lim, who contribute to his research endeavors.
Conclusion
Thirunavukkarasu Velusamy is a dedicated inventor whose work in cancer research is paving the way for innovative diagnostic and therapeutic solutions. His contributions are vital to the ongoing fight against cancer.